In terms of prognostic risk factors, HER2 positivity, BM surgical resection, and diagnosis after 2014 were associated with ...

The U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal ...

Dave Nitsche, a nonsmoker and athlete, was diagnosed with stage 4 lung cancer after vision loss led to the discovery of ...

About 170,000 women in the United States are living with metastatic breast cancer—or cancer that has spread to other ...

Puma Biotechnology has one approved drug, strong cash, and is developing alisertib with key ALISCA trial readouts in 1H 2026.

Allogene Therapeutics, Inc. downgraded to Hold after ALPHA3 trial setbacks. Review updated pipeline prospects and risks.

Metsera's lead pipeline asset is MET-097i, a GLP-1 receptor agonist designed for once-monthly injection. Novo's weight-loss drugs Wegovy and Eli Lilly's Zepbound and Mounjaro require weekly injections ...

Breast cancer is commonly portrayed as challenging yet curable: A lump is discovered, then through some combination of ...

Metastatic melanoma cells that have spread to lymph nodes survive by relying on a protein called ferroptosis suppressor protein 1 (FSP1)—a surprising metabolic dependency that could open the door to a ...

Working with the same tumor slices that pathologists use to diagnose and guide treatment of patients, however, Carstens can ...

Pluvicto represents a breakthrough in the fight against advanced prostate cancer. This radioligand therapy targets the prostate-specific membrane antigen (PSMA) on cancer cells. It delivers radiation ...